Trulieve has transformed from an OTC-bound cannabis operator into a NYSE-listed, cash-generative medical cannabis leader with asymmetric upside from tax relief, institutional capital access, and future adult-use optionality.
Overview
Trulieve is a leading vertically integrated U.S. medical cannabis operator that became the first plant-touching cannabis company to list on the NYSE after restructuring its adult-use assets into Harvest Enterprises. The new consolidated company focuses on state-licensed medical cannabis across Florida, Georgia, Pennsylvania, and West Virginia, supported by 206 medical dispensaries and 3.5 million square feet of DEA-registered production capacity. The investment story centers on medical retail scale, high-margin branded products, 280E tax relief, and unprecedented access to senior U.S. capital markets.